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The Neuroendocrine System, an
Opportunity for Immunotoxicologists
by Carroll A. Snyder*
The interrelationship between the neuroendocrine and immune systems was first recognized over 50 years
ago. Subsequent investigations have shown that gene products produced by the neuroendocrine system af-
fect the activities ofimmunologically competent cells. More recent data show that cells ofthe two systems
possess receptors that are identical. Because ofthese strong interrelationships, it is postulated that compounds
that affect the neuroendocrine system will also affect the immune system. It follows that the readily acces-
sible cells ofthe immune system can be used as surrogates forthe less accessible cells ofthe neuroendocrine
system. Moreover, the assays typically used by immunotoxicologists could provide quantitative information
regarding dose response, persistence ofeffects, and surveillance ofthe extent ofexposure forcompounds known
to be neurotoxicants. Thus, much useful information could be acquired by applying the technique of im-
munotoxicology to the study of neurotoxicants.
In 1936, Hans Selye published the results of a series of
studieswhich showedthat the same sequelae ofpatholog-
ical changes could be produced when rats were exposed
to widely diverse stress-inducing agents (1). Repeated
acute exposures to physical stressors such as cold temper-
atures, surgical injury, spinal shock, and excessive exer-
cise induced the same responses as repeated exposures
to anumberofchemical compounds, includingadrenaline,
atropine, morphine, and formaldehyde. The responses de-
veloped in three distinct stages. The first occurred within
48 hr afterthe onset oftreatment andconsisted of arapid
decrease in the sizes of the thymus, spleen, and lymph
nodes accompanied by aloss ofchromaffin substance and
lipoid in the adrenals. The second stage occurred shortly
after the first and was characterized by greatly enlarged
adrenals and hyperplasia ofthe thyroid. Iftreatment was
continued, there was atransient return to normal appear-
ance and function in the affected organs; however, this
was followed by a reappearance ofthe original responses
andultimately, death. Thislastphase was considered the
third stage ofthe syndrome. Selye subsequently termed
the induction of these diverse physiologic changes "the
stress syndrome" (2).
Selye's observations are believed to be the first to
clearly show that the organs ofthe neuroendocrine sys-
tem and those ofthe immune system were interrelated.
More importantly, from a toxicological perspective, he
demonstrated that the same chemical could adversely af-
fect both organ systems.
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Selye's findings were an incentive for further studies
into the relationship between the neuroendocrine and im-
mune systems. It was subsequently determined that the
application ofstressors couldprofoundly affect anumber
ofimmune-associated parameters. Amongthese were sus-
ceptibility to Herpes virus, decreased subsceptibility to
passive anaphylaxis and reduced allografttransplantation
immunity [see Wistar and Hildemann (3) for a summary
ofearly studies concerningimmunity and stress]. It was
further demonstrated that administration ofcompounds
produced by the adrenal cortex such as cortisone and
hydrocortisone could mimic the immunosuppressive ef-
fects inducedbyapplicationofstressors(3). Moreover, ad-
ministration ofthese compounds couldmarkedly slowthe
development ofspontaneous orX-ray inducedthymiclym-
phoma in mice (4-6). Thus, corticosteroids were found to
haveprofound effects on the activities ofbothnormal and
malignant cells of the immune system.
There is nowfirm evidence that modulation ofthe im-
mune systemby the neuroendocrine system is not medi-
ated solely by corticosteroids. Opioids have beenfound to
be capable of altering a number of responses of both
T-cells and natural killer(NK) cells(7-9). Studieswith one
opioid,13-endorphin, have shown that the immunomodula-
tory effects of this compound are mediated via specific
receptors found on T-cells (7,10). There is evidence that
the corticosteroids also modulate the immune response
through aspecificmechanism rather thanbynonspecific
cell lysis (11,12). These findings have spurred investiga-
tions into the nature ofthe receptors found on the cells
ofboth the neuroendocrine and immune systems. It now
appears that immunologically competent cells possess
receptors that are very similar to orperhapsidentical to166 C. A. SNYDER
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FIGURE 1. Interaction ofneurotoxicants with the immune system. In-
direct pathway: A compound can affect the immune system by first
inducing stress, which, in turn, produces changes in the neuroendo-
crine system that alter immune function. Immunological assays could
beusedto monitorquantitative aspectsofsuchexposures, Directpath-
way: A compound can interact directly with gene products common
to both lymphocytes (L cell) and neuroendocrine cells (N cells). The
same type ofdamagewouldbeproducedinbothtypes ofcells. Readily
accessible lymphocytes can be used as surrogates to assess the
molecular damage in the less accessible neuroendocrine cells.
some ofthe receptors found on neurons and muscle cells
(13). For example, the P-receptors long known to be pos-
sessed by neurons have recently been found on
T-suppressor cells (13).
The interrelationship between the immune and neu-
roendocrine systems provides anopportunity to applythe
quantitative assays routinely employedbyimmunotoxicol-
ogists to the study ofcompounds thataffect the neuroen-
docrine system. Three areas of study come to mind
wherein immunotoxicology assays couldbe used to assess
the activities ofneuroendocrine toxicants. The first area
concerns exposure to compounds that primarily induce
stress that in turn causes alterations ofboth the immune
and neuroendocrine systems (Fig. 1). Such compounds
might be termed "indirect neurotoxicants" and might
cause stressbecause oftheirirritantproperties. The neu-
rotoxic effects ofsuch compounds could be monitored by
behavioral toxicological assays, but quantitative assess-
ment of their effects such as dose-response information
and persistence ofeffects after exposure might be better
assessed by immune function assays.
The second areaconcerns exposure to compounds that
directly alter receptors or other gene products common
to cells ofboth the neuroendocrine and immune systems
(Fig. 1). Such compounds might be called "direct neu-
rotoxicants." The more readily accessible cells ofthe im-
mune systemwouldbe useful surrogatesforassessingthe
molecular damage inflicted by direct neurotoxicants on
the less accessible cells of neuroendocrine system.
The third areais a variation ofthe second and consists
ofusing the cells ofthe immune system for surveillance
of the effects of exposure to neurotoxicants. This tech-
nique is already being applied to monitor farm workers
handling organophosphorus defoliants (14). Although ex-
posures to the defoliants did not induce any clinical effects
on the peripheral nervous system, the activity of an es-
terase commonto bothlymphocytes andnerve tissue was
inhibited by the exposures. Moreover, the extent ofinhi-
bition of the activity of the esterase was found to be a
function of length and intensity of exposure. Thus,
peripheral lymphocytes were used to determine the ex-
tent of exposure to compounds known to produce neu-
rotoxicity (14).
In summary, it seems that the application of immune
function assays to the study of compounds known to be
neurotoxicants would provide much useful quantitative
toxicological information as well as continue the study of
the interrelationships between the immune and endocrine
system described by Hans Selye over 50 years ago.
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